Magnesium Sulfate–Mediated Inflammatory Modulation in High‐Risk Pregnancies: Dynamic Shifts in CBC‐Derived Markers Predict Neonatal Outcomes
American Journal of Reproductive Immunology · 2025
DOI: 10.1111/aji.70172 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2025. Verfasst von Şebnem Karagün und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Division of Perinatology, Mersin University Faculty of Medicine, Mersin, Turkey. Hauptthemen laut MEDLINE: Magnesium Sulfate, Inflammation, Pregnancy, High-Risk. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Objective
To evaluate the effect of magnesium sulfate (MgSO 4 ) therapy on dynamic changes in maternal inflammation‐based hematologic indices and their predictive value for neonatal outcomes in high‐risk pregnancies.
Methods
We conducted a retrospective cohort study involving 236 singleton pregnancies treated with MgSO 4 for either fetal neuroprotection or seizure prophylaxis. Pre‐ and 24‐h post‐treatment complete blood count (CBC)—derived inflammatory markers (including neutrophil‐to‐lymphocyte ratio [NLR], platelet‐to‐lymphocyte ratio [PLR], systemic inflammation response index [SIRI], and mean platelet volume [MPV]) were compared. Percentage change (Δ) values were calculated. Associations between these Δ‐values and adverse perinatal outcomes were analyzed using correlation tests and ROC curves.
Results
Following MgSO 4 administration, significant alterations were observed in maternal inflammatory markers: NLR (+12.2%), WBC (+11.7%), SIRI (+25.6%) increased, whereas PLR (−9.7%), LMR (−6.1%), and platelet count (−9.6%) decreased (all p < 0.05). ΔNLR, ΔMPV, and ΔWBC correlated negatively with gestational age and birth weight, and positively with NICU admission. ROC analysis identified ΔNLR ≥ −15.132 as a predictor of NICU admission (AUC = 0.609, p = 0.016).
Conclusion
Magnesium sulfate induces measurable changes in maternal inflammatory profiles. These dynamic hematologic shifts—especially in NLR and MPV—may carry limited predictive value for adverse neonatal outcomes. Monitoring ∆‐inflammatory indices could support exploratory efforts in risk stratification, but further validation is required before clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Division of Perinatology, Mersin University Faculty of Medicine, Mersin, Turkey.
- Department of Obstetrics and Gynecology, Mersin University Faculty of Medicine, Mersin, Turkey.
- Department of Obstetrics and Gynecology, Division of Gynecological Oncology Surgery, Mersin University Faculty of Medicine, Mersin, Turkey.
ORCID-Profile: Şebnem Karagün, Hamza Yıldız, Yusuf Dal, Ahmet Zeki Nessar, Sefanur Gamze Karaca, Mürşide Çevikoğlu Kıllı, Ayhan Coşkun
Zitieren
APA
Karagün, Ş., Yıldız, H., Dal, Y., Nessar, A. Z., Karaca, S. G., Kıllı, M. Ç., & Coşkun, A. (2025). Magnesium Sulfate–Mediated Inflammatory Modulation in High‐Risk Pregnancies: Dynamic Shifts in CBC‐Derived Markers Predict Neonatal Outcomes. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70172
Vancouver
Karagün Ş, Yıldız H, Dal Y, Nessar AZ, Karaca SG, Kıllı MÇ, et al. Magnesium Sulfate–Mediated Inflammatory Modulation in High‐Risk Pregnancies: Dynamic Shifts in CBC‐Derived Markers Predict Neonatal Outcomes. American Journal of Reproductive Immunology. 2025. doi:10.1111/aji.70172
BibTeX
@article{Karagn2025,
author = {Karagün, Şebnem and Yıldız, Hamza and Dal, Yusuf and Nessar, Ahmet Zeki and Karaca, Sefanur Gamze and Kıllı, Mürşide Çevikoğlu and Coşkun, Ayhan},
title = {Magnesium Sulfate–Mediated Inflammatory Modulation in High‐Risk Pregnancies: Dynamic Shifts in CBC‐Derived Markers Predict Neonatal Outcomes},
journal = {American Journal of Reproductive Immunology},
year = {2025},
doi = {10.1111/aji.70172}
}
EUVIMED